Julia Kim

Biomarker Testing Patterns and Treatment Outcomes in Patients With Advanced Non-Small Cell Lung Cancer and MET Exon 14 Skipping Mutations: A Descriptive Analysis From the US

M. Shi, Shiyu Zhang, F. Asad Zadeh Vosta Kolaei, 2022, Frontiers in Oncology.

Overexpression of microRNA-145 inhibits tumorigenesis through autophagy in chemotherapy and radiation resistant neuroblastoma cells

D. Chung, K. W. Kim, J. Qiao, 2020, Oncoscience.

Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma

R. Clark, D. Chung, K. W. Kim, 2019, Oncotarget.